Literature DB >> 20140427

Olanzapine and pancytopenia with severe folate deficiency.

F Maurier, N Petitpain, J-F Guichard, L Javot, P Tréchot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20140427     DOI： 10.1007/s00228-010-0788-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  One further case of pancytopenia induced by olanzapine in a Parkinson's disease patient.

Authors:  M Onofrj; A Thomas
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

2.  Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.

Authors:  O Bogunovic; R Viswanathan
Journal:  Psychosomatics       Date:  2000 May-Jun       Impact factor: 2.386

3.  Thrombocytopenia and fatality associated with olanzapine.

Authors:  Juan Antonio Carrillo; José Antonio González; Guillermo Gervasini; Rosa López; María Angeles Fernández; Guillermo Martín Núñez
Journal:  Eur J Clin Pharmacol       Date:  2004-05-19       Impact factor: 2.953

4.  In vitro toxicity of clozapine, olanzapine, and quetiapine on granulocyte-macrophage progenitors (GM-CFU).

Authors:  A Pessina; E Turlizzi; A Bonomi; F Guizzardi; L Cavicchini; C Croera; S Bareggi
Journal:  Pharmacopsychiatry       Date:  2006-01       Impact factor: 5.788

5.  Cough mixture abuse as a novel cause of folate deficiency: a prospective, community-based, controlled study.

Authors:  Wing-yan Au; Suk-Kwan Tsang; Ben K L Cheung; Tak-Shing Siu; Edmond S K Ma; Sidney Tam
Journal:  Haematologica       Date:  2007-04       Impact factor: 9.941

6.  Olanzapine-induced thrombocytopenia in association with idiopathic thrombocytopenic purpura.

Authors:  S Bachmann; J Schröder; J Pantel; C Mundt; M Zorn; M Witzens; G Egerer
Journal:  Br J Psychiatry       Date:  1998-10       Impact factor: 9.319

7.  Prolongation of clozapine-induced granulocytopenia associated with olanzapine.

Authors:  S W Flynn; S Altman; G W MacEwan; L L Black; L L Greenidge; W G Honer
Journal:  J Clin Psychopharmacol       Date:  1997-12       Impact factor: 3.153

Review 8.  Olanzapine-induced agranulocytosis: a case report and review of the literature.

Authors:  Carles Tolosa-Vilella; Ada Ruiz-Ripoll; Begoña Mari-Alfonso; Elsa Naval-Sendra
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

9.  Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs.

Authors:  Vincenzo Belcastro; Pasquale Striano; Gaetano Gorgone; Cinzia Costa; Clotilde Ciampa; Daniela Caccamo; Laura R Pisani; Giancarla Oteri; Maria G Marciani; Umberto Aguglia; Salvatore Striano; Riccardo Ientile; Paolo Calabresi; Francesco Pisani
Journal:  Epilepsia       Date:  2009-09-22       Impact factor: 5.864

10.  Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.

Authors:  Z C Liu; J P Uetrecht
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030
  10 in total
  2 in total

1.  Olanzapine-associated leukopenia and thrombocytopenia managed with lithium in a patient who developed leukopenia with clozapine in the past: a case report.

Authors:  Sandeep Grover; Aditya Hegde; Munish Agarwal; Manupdesh Singh Sachdeva
Journal:  Prim Care Companion CNS Disord       Date:  2012

2.  Thrombocytopenia associated with olanzapine: A case report and review of literature.

Authors:  Swapnajeet Sahoo; Himanshu Singla; M Spoorty; Pankaj Malhotra; Sandeep Grover
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.